Ferritin levels and recovery in diabetic ketoacidosis
Part of Hormones & metabolism clinical trials.
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have type 1 or type 2 diabetes and are currently in diabetic ketoacidosis (DKA).
- You do not have iron deficiency anemia or iron overload.
- You do not have an active infection (bacterial, viral, or fungal).
- You do not have other serious health conditions like heart attack, stroke, kidney disease, liver disease, cancer, or are pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple blood test, the leukocyte glucose index, to see if it can help doctors judge how severe diabetic ketoacidosis (a serious diabetes complication) is. It aims to find a reliable way to predict recovery and guide treatment.
This trial tests if an IV medicine called arginine hydrochloride can help manage diabetic ketoacidosis (DKA) in people with type 2 diabetes. It's for those who come to the ER with very high blood sugar and ketones.
This study looks at a simple, non-invasive measurement called the perfusion index, which shows how well blood is flowing to your tissues, to help doctors quickly determine how severe diabetic ketoacidosis (a serious diabetes complication) is. The goal is to see if this measurement can guide treatment and improve outcomes.
This trial tests a solution called REAMBERIN to help rehydrate people with diabetic ketoacidosis (DKA). If you are 18–75 and have DKA with very high blood sugar and acidic blood, you may be able to join.
This study looks at signs of acute organ injury in children newly diagnosed with type 1 diabetes. It aims to understand how the body reacts to diabetes and its treatment, which could help improve care for kids like yours.
This study looks at how diabetes-related blood sugar and metabolic problems affect the recovery and outcomes of people with chronic kidney disease who are in the hospital. By tracking these patients, doctors hope to learn how to better manage their care while hospitalized.
Hear when a new Diabetic Ketoacidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.